The DOI matches its Crossref record; 276 of the 276 references it cites were found in a registry or an index.
Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
Open accessAbstract
Tumor-associated macrophages (TAMs) are major innate immune cells that constitute up to 50% of the cell mass of human tumors. TAMs are highly heterogeneous cells that originate from resident tissue-specific macrophages and from newly recruited monocytes. TAMs' variability strongly depends on cancer type, stage, and intratumor heterogeneity. Majority of TAMs are programmed by tumor microenvironment to support primary tumor growth and metastatic spread. However, TAMs can also restrict tumor growth and metastasis. In this review, we summarized the knowledge about the role of TAMs in tumor growth, metastasis and in the response to cancer therapy in patients with five aggressive types of cancer: breast, colorectal, lung, ovarian, and prostate cancers that are frequently metastasize into distant organs resulting in high mortality of the patients. Two major TAM parameters are applied for the evaluation of TAM correlation with the cancer progression: total amount of TAMs and specific phenotype of TAMs identified by functional biomarkers. We summarized the data generated in the wide range of international patient cohorts on the correlation of TAMs with clinical and pathological parameters of tumor progression including lymphatic and hematogenous metastasis, recurrence, survival, therapy efficiency. We described currently available biomarkers for TAMs that can be measured in patients' samples (tumor tissue and blood). CD68 is the major biomarker for the quantification of total TAM amounts, while transmembrane receptors (stabilin-1, CD163, CD206, CD204, MARCO) and secreted chitinase-like proteins (YKL-39, YKL-40) are used as biomarkers for the functional TAM polarization. We also considered that specific role of TAMs in tumor progression can depend on the localization in the intratumoral compartments. We have made the conclusion for the role of TAMs in primary tumor growth, metastasis, and therapy sensitivity for breast, colorectal, lung, ovarian, and prostate cancers. In contrast to other cancer types, majority of clinical studies indicate that TAMs in colorectal cancer have protective role for the patient and interfere with primary tumor growth and metastasis. The accumulated data are essential for using TAMs as biomarkers and therapeutic targets to develop cancer-specific immunotherapy and to design efficient combinations of traditional therapy and new immunomodulatory approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Global Burden of Disease Cancer Collaboration, Fitzmaurice, C., Allen, C., Barber, R. M., Barregard, L., Bhutta, Z. A., Brenner, H., Dicker, D. J., Chimed-Orchir, O., Dandona, R., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5688 · Cited by 6,215
Global patterns and trends in colorectal cancer incidence and mortality
Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2017) · Gut · doi:10.1136/gutjnl-2015-310912 · Cited by 5,228
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Lung cancer: current therapies and new targeted treatments
Hirsch, F. R., Scagliotti, G. V., Mulshine, J. L., Kwon, R., Curran, W. J., Wu, Y.-L., & Paz-Ares, L. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30958-8 · Cited by 3,283
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Aebi, S., Davidson, T., Gruber, G., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq159 · Cited by 2,842
Allemani, C., Weir, H. K., Carreira, H., Harewood, R., Spika, D., Wang, X.-S., Bannon, F., Ahn, J. V., Johnson, C. J., Bonaventure, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62038-9 · Cited by 2,614
Global Burden of Disease Cancer Collaboration, Fitzmaurice, C., Abate, D., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdel-Rahman, O., Abdelalim, A., Abdoli, A., Abdollahpour, I., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.2996 · Cited by 2,501
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Cardoso, F., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rubio, I. T., Zackrisson, S., & Senkus, E. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz173 · Cited by 2,214
Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
Duma, N., Santana-Davila, R., & Molina, J. R. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.01.013 · Cited by 2,184
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
Ovarian Cancer Development and Metastasis
Lengyel, E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100105 · Cited by 1,672
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Watson, P. A., Arora, V. K., & Sawyers, C. L. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4016 · Cited by 1,536
Epidemiology of ovarian cancer: a review
Brett M., R., Brett M., R., Jennifer B., P., Thomas A., S., Jennifer B., P., & Thomas A., S. (2017) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2016.0084 · Cited by 1,524
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
Solinas, G., Germano, G., Mantovani, A., & Allavena, P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609385 · Cited by 1,425
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
Leek, R., Lewis, C. E., Whitehouse, R. M., Greenall, M. J., Clarke, J., & Harris, A. L. (1996) · PubMed · Cited by 1,187
Lin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
Macrophages Regulate the Angiogenic Switch in a Mouse Model of Breast Cancer
Lin, E. Y., Li, J.-F., Gnatovskiy, L., Deng, Y., Zhu, L., Grzesik, D. A., Qian, H., Xue, X.-N., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1278 · Cited by 1,074
Lung cancer: Biology and treatment options
Lemjabbar-Alaoui, H., Hassan, O. U., Yang, Y.-W., & Buchanan, P. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.08.002 · Cited by 1,014
Spring, L. M., Fell, G., Arfe, A., Sharma, C., Greenup, R., Reynolds, K. L., Smith, B. L., Alexander, B., Moy, B., Isakoff, S. J., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3492 · Cited by 938
Cassetta, L., Fragkogianni, S., Sims, A. H., Swierczak, A., Forrester, L. M., Zhang, H., Soong, D. Y. H., Cotechini, T., Anur, P., Lin, E. Y., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.02.009 · Cited by 920
Wei, C., Yang, C., Wang, S., Shi, D., Zhang, C., Lin, X., Liu, Q., Dou, R., & Xiong, B. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0976-4 · Cited by 833
The Epidemiology of Prostate Cancer
Pernar, C. H., Ebot, E. M., Wilson, K. M., & Mucci, L. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030361 · Cited by 773
Genetics and biology of prostate cancer
Wang, G., Zhao, D., Spring, D. J., & DePinho, R. A. (2018) · Genes & Development · doi:10.1101/gad.315739.118 · Cited by 750
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
Kryczek, I., Zou, L., Rodriguez, P., Zhu, G., Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050930 · Cited by 748
Rolny, C., Mazzone, M., Tugues, S., Laoui, D., Johansson, I., Coulon, C., Squadrito, M. L., Segura, I., Li, X., Knevels, E., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.009 · Cited by 695
Much More than M1 and M2 Macrophages, There are also CD169+ and TCR+ Macrophages
Chávez-Galán, L., Olleros, M. L., Vesin, D., & Garcia, I. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00263 · Cited by 653
Medrek, C., Pontén, F., Jirström, K., & Leandersson, K. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-306 · Cited by 647
Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
Riabov, V., Gudima, A., Wang, N., Mickley, A., Orekhov, A., & Kzhyshkowska, J. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00075 · Cited by 628
Self-citationAli, H. R., Chlon, L., Pharoah, P. D. P., Markowetz, F., & Caldas, C. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002194 · Cited by 615
Clinical Diagnosis and Management of Breast Cancer
McDonald, E. S., Clark, A. S., Tchou, J., Zhang, P., & Freedman, G. M. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.157834 · Cited by 613
Tissue macrophages: heterogeneity and functions
Gordon, S., & Plüddemann, A. (2017) · BMC Biology · doi:10.1186/s12915-017-0392-4 · Cited by 603
Gao, J., Ward, J. F., Pettaway, C. A., Shi, L. Z., Subudhi, S. K., Vence, L. M., Zhao, H., Chen, J., Chen, H., Efstathiou, E., et al. (2017) · Nature Medicine · doi:10.1038/nm.4308 · Cited by 594
High Macrophage Infiltration along the Tumor Front Correlates with Improved Survival in Colon Cancer
Forssell, J., Öberg, A., Henriksson, M. L., Stenling, R., Jung, A., & Palmqvist, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2073 · Cited by 566
Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
Guerriero, J. L., Sotayo, A., Ponichtera, H. E., Castrillon, J. A., Pourzia, A. L., Schad, S., Johnson, S. F., Carrasco, R. D., Lazo, S., Bronson, R. T., et al. (2017) · Nature · doi:10.1038/nature21409 · Cited by 558
Molecular Classification of Breast Cancer
Tsang, J. Y. S., & Tse, G. M. (2020) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000232 · Cited by 556
Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
Shree, T., Olson, O. C., Elie, B. T., Kester, J. C., Garfall, A. L., Simpson, K., Bell-McGuinn, K. M., Zabor, E. C., Brogi, E., & Joyce, J. A. (2011) · Genes & Development · doi:10.1101/gad.180331.111 · Cited by 541
Martinez-Pomares, L. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0512231 · Cited by 531
Comito, G., Giannoni, E., Segura, C. P., Barcellos-de-Souza, P., Raspollini, M. R., Baroni, G., Lanciotti, M., Serni, S., & Chiarugi, P. (2014) · Oncogene · doi:10.1038/onc.2013.191 · Cited by 528
Zhang, M., He, Y., Sun, X., Li, Q., Wang, W., Zhao, A., & Di, W. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-19 · Cited by 528
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Hughes, R., Qian, B.-Z., Rowan, C., Muthana, M., Keklikoglou, I., Olson, O. C., Tazzyman, S., Danson, S., Addison, C., Clemons, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3587 · Cited by 518
Nagpal, K., Foote, D., Liu, Y., Chen, P.-H. C., Wulczyn, E., Tan, F., Olson, N., Smith, J. L., Mohtashamian, A., Wren, J. H., et al. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0112-2 · Cited by 495
Piawah, S., & Venook, A. P. (2019) · Cancer · doi:10.1002/cncr.32163 · Cited by 488
The inflammatory microenvironment and microbiome in prostate cancer development
Sfanos, K. S., Yegnasubramanian, S., Nelson, W. G., & De Marzo, A. M. (2018) · Nature Reviews Urology · doi:10.1038/nrurol.2017.167 · Cited by 469
Edin, S., Wikberg, M. L., Dahlin, A. M., Rutegård, J., Öberg, Å., Oldenborg, P.-A., & Palmqvist, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047045 · Cited by 454
Wanderley, C. W., Colón, D. F., Luiz, J. P. M., Oliveira, F. F., Viacava, P. R., Leite, C. A., Pereira, J. A., Silva, C. M., Silva, C. R., Silva, R. L., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3480 · Cited by 420
Yin, M., Li, X., Tan, S., Zhou, H. J., Ji, W., Bellone, S., Xu, X., Zhang, H., Santin, A. D., Lou, G., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87252 · Cited by 417
Lo Russo, G., Moro, M., Sommariva, M., Cancila, V., Boeri, M., Centonze, G., Ferro, S., Ganzinelli, M., Gasparini, P., Huber, V., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1390 · Cited by 408
Wimberly, H., Brown, J. R., Schalper, K., Haack, H., Silver, M. R., Nixon, C., Bossuyt, V., Pusztai, L., Lannin, D. R., & Rimm, D. L. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0133 · Cited by 397
Cancer Invasion: Patterns and Mechanisms
Krakhmal, N. V., Zavyalova, M. V., Denisov, E. V., Vtorushin, S. V., & Perelmuter, V. M. (2015) · Acta Naturae · doi:10.32607/20758251-2015-7-2-17-28 · Cited by 374
Testa, U., Pelosi, E., & Castelli, G. (2018) · Medical Sciences · doi:10.3390/medsci6020031 · Cited by 374
Can advanced-stage ovarian cancer be cured?
Narod, S. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.224 · Cited by 369
Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy
Van Gorp, H., Delputte, P. L., & Nauwynck, H. J. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.02.008 · Cited by 357
Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study
Wu, Q., Li, J., Zhu, S., Wu, J., Chen, C., Liu, Q., Wei, W., Zhang, Y., & Sun, S. (2017) · Oncotarget · doi:10.18632/oncotarget.15856 · Cited by 355
Henderson, J. T., Webber, E. M., & Sawaya, G. F. (2018) · JAMA · doi:10.1001/jama.2017.21421 · Cited by 348
Zhao, X., Qu, J., Sun, Y., Wang, J., Liu, X., Wang, F., Zhang, H., Wang, W., Ma, X., Gao, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15736 · Cited by 345
Real-world evidence in the treatment of ovarian cancer
Eisenhauer, E. A. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx443 · Cited by 344
Lissbrant, I. F., Stattin, P., Wikstrom, P., Damber, J. E., Egevad, L., & Bergh, A. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.3.445 · Cited by 333
Global analysis of advanced/metastatic breast cancer: decade report (2005-2015)
Cardoso, F., Spence, D., Mertz, S., Corneliussen-James, D., Sabelko, K., Gralow, J., Cardoso, M.-J., Peccatori, F., Paonessa, D., Benares, A., et al. (2018) · The Breast · doi:10.1016/j.breast.2018.03.002 · Cited by 324
Interaction of tumor-associated macrophages and cancer chemotherapy
Larionova, I., Cherdyntseva, N., Liu, T., Patysheva, M., Rakina, M., & Kzhyshkowska, J. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1596004 · Cited by 322
Self-citationDiagnosis and Treatment of Ovarian Cancer
Orr, B., & Edwards, R. P. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.07.010 · Cited by 322
Tissue‐resident macrophages in omentum promote metastatic spread of ovarian cancer
Etzerodt, A., Moulin, M., Doktor, T. K., Delfini, M., Mossadegh-Keller, N., Bajenoff, M., Sieweke, M. H., Moestrup, S. K., Auphan-Anezin, N., & Lawrence, T. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20191869 · Cited by 305
Macrophages of distinct origins contribute to tumor development in the lung
Loyher, P.-L., Hamon, P., Laviron, M., Meghraoui-Kheddar, A., Goncalves, E., Deng, Z., Torstensson, S., Bercovici, N., Baudesson de Chanville, C., Combadière, B., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180534 · Cited by 298
The Treatment of Breast Cancer
(1974) · Springer eBooks · doi:10.1007/978-94-011-7152-6 · Cited by 280
The prognostic significance of lymphovascular invasion in invasive breast carcinoma
Rakha, E. A., Martin, S., Lee, A. H. S., Morgan, D., Pharoah, P. D. P., Hodi, Z., MacMillan, D., & Ellis, I. O. (2012) · Cancer · doi:10.1002/cncr.26711 · Cited by 271
Shimura, S., Yang, G., Ebara, S., Wheeler, T. M., Frolov, A., & Thompson, T. C. (2000) · PubMed · Cited by 271
Gannon, P. O., Poisson, A. O., Delvoye, N., Lapointe, R., Mes-Masson, A.-M., & Saad, F. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.004 · Cited by 261
Jackute, J., Zemaitis, M., Pranys, D., Sitkauskiene, B., Miliauskas, S., Vaitkiene, S., & Sakalauskas, R. (2018) · BMC Immunology · doi:10.1186/s12865-018-0241-4 · Cited by 261
Schmall, A., Al-tamari, H. M., Herold, S., Kampschulte, M., Weigert, A., Wietelmann, A., Vipotnik, N., Grimminger, F., Seeger, W., Pullamsetti, S. S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201406-1137oc · Cited by 259
Cassetta, L., & Pollard, J. W. (2020) · Current Biology · doi:10.1016/j.cub.2020.01.031 · Cited by 258
Role of macrophage scavenger receptors in atherosclerosis
Kzhyshkowska, J., Neyen, C., & Gordon, S. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.02.015 · Cited by 255
Self-citationPrognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis
Yuan, X., Zhang, J., Li, D., Mao, Y., Mo, F., Du, W., & Ma, X. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.07.007 · Cited by 250
Paschke, S., Jafarov, S., Staib, L., Kreuser, E.-D., Maulbecker-Armstrong, C., Roitman, M., Holm, T., Harris, C. C., Link, K.-H., & Kornmann, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092577 · Cited by 249
Ontogeny of Tumor-Associated Macrophages
Laviron, M., & Boissonnas, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01799 · Cited by 239
Tiainen, S., Tumelius, R., Rilla, K., Hämäläinen, K., Tammi, M., Tammi, R., Kosma, V., Oikari, S., & Auvinen, P. (2015) · Histopathology · doi:10.1111/his.12607 · Cited by 234
Paulus, P., Stanley, E. R., Schäfer, R., Abraham, D., & Aharinejad, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3523 · Cited by 231
Lan, C., Huang, X., Lin, S., Huang, H., Cai, Q., Wan, T., Lu, J., & Liu, J. (2013) · Technology in Cancer Research & Treatment · doi:10.7785/tcrt.2012.500312 · Cited by 227
Li, D., Ji, H., Niu, X., Yin, L., Wang, Y., Gu, Y., Wang, J., Zhou, X., Zhang, H., & Zhang, Q. (2020) · Cancer Science · doi:10.1111/cas.14230 · Cited by 227
Outcomes and endpoints in trials of cancer treatment: the past, present, and future
Wilson, M. K., Karakasis, K., & Oza, A. M. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70375-4 · Cited by 219
Escamilla, J., Schokrpur, S., Liu, C., Priceman, S. J., Moughon, D., Jiang, Z., Pouliot, F., Magyar, C., Sung, J. L., Xu, J., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-0992 · Cited by 219
Zhou, Q., Peng, R.-Q., Wu, X.-J., Xia, Q., Hou, J.-H., Ding, Y., Zhou, Q.-M., Zhang, X., Pang, Z.-Z., Wan, D.-S., et al. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-13 · Cited by 219
Yuan, Z.-Y., Luo, R.-Z., Peng, R.-J., Wang, S.-S., & Xue, C. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s61838 · Cited by 214
The Two Faces of Tumor-Associated Macrophages and Their Clinical Significance in Colorectal Cancer
Pinto, M. L., Rios, E., Durães, C., Ribeiro, R., Machado, J. C., Mantovani, A., Barbosa, M. A., Carneiro, F., & Oliveira, M. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01875 · Cited by 213
Kzhyshkowska, J., Mamidi, S., Gratchev, A., Kremmer, E., Schmuttermaier, C., Krusell, L., Haus, G., Utikal, J., Schledzewski, K., Scholtze, J., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2843 · Cited by 212
Self-citationKawamura, K., Komohara, Y., Takaishi, K., Katabuchi, H., & Takeya, M. (2009) · Pathology International · doi:10.1111/j.1440-1827.2009.02369.x · Cited by 210
Huang, A., Zhang, B., Wang, B., Zhang, F., Fan, K.-X., & Guo, Y.-J. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1450-6 · Cited by 210
Macrophages Mediate Inflammation-Enhanced Metastasis of Ovarian Tumors in Mice
Robinson-Smith, T. M., Isaacsohn, I., Mercer, C. A., Zhou, M., Van Rooijen, N., Husseinzadeh, N., McFarland-Mancini, M. M., & Drew, A. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4375 · Cited by 199
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target
Zhao, S. G., Lehrer, J., Chang, S. L., Das, R., Erho, N., Liu, Y., Sjöström, M., Den, R. B., Freedland, S. J., Klein, E. A., et al. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy141 · Cited by 198
Nonomura, N., Takayama, H., Nakayama, M., Nakai, Y., Kawashima, A., Mukai, M., Nagahara, A., Aozasa, K., & Tsujimura, A. (2011) · BJU International · doi:10.1111/j.1464-410x.2010.09804.x · Cited by 197
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications
Testa, U., Castelli, G., & Pelosi, E. (2019) · Medicines · doi:10.3390/medicines6030082 · Cited by 194
Argyle, D., & Kitamura, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02629 · Cited by 190
Wang, R., Zhang, J., Chen, S., Lu, M., Luo, X., Yao, S., Liu, S., Qin, Y., & Chen, H. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.04.009 · Cited by 189
Stromal Macrophage Expressing CD204 is Associated with Tumor Aggressiveness in Lung Adenocarcinoma
Ohtaki, Y., Ishii, G., Nagai, K., Ashimine, S., Kuwata, T., Hishida, T., Nishimura, M., Yoshida, J., Takeyoshi, I., & Ochiai, A. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181eba692 · Cited by 185
Immune Infiltration and Prostate Cancer
Strasner, A., & Karin, M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00128 · Cited by 184
Macciò, A., Gramignano, G., Cherchi, M. C., Tanca, L., Melis, L., & Madeddu, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-63276-1 · Cited by 179
Reconsidering Prostate Cancer Mortality — The Future of PSA Screening
Welch, H. G., & Albertsen, P. C. (2020) · New England Journal of Medicine · doi:10.1056/nejmms1914228 · Cited by 179
Ontogeny of Tumor-Associated Macrophages and Its Implication in Cancer Regulation
Franklin, R. A., & Li, M. O. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2015.11.004 · Cited by 175
Novel Function of Alternatively Activated Macrophages: Stabilin-1-Mediated Clearance of SPARC
Kzhyshkowska, J., Workman, G., Cardó-Vila, M., Arap, W., Pasqualini, R., Gratchev, A., Krusell, L., Goerdt, S., & Sage, E. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.5825 · Cited by 174
Self-citationTumor‐associated macrophages (TAMs) depend on ZEB1 for their cancer‐promoting roles
Cortés, M., Sanchez‐Moral, L., de Barrios, O., Fernández‐Aceñero, M. J., Martínez‐Campanario, M., Esteve‐Codina, A., Darling, D. S., Győrffy, B., Lawrence, T., Dean, D. C., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201797345 · Cited by 174
M2 macrophages and regulatory T cells in lethal prostate cancer
Erlandsson, A., Carlsson, J., Lundholm, M., Fält, A., Andersson, S., Andrén, O., & Davidsson, S. (2019) · The Prostate · doi:10.1002/pros.23742 · Cited by 174
Tumor Heterogeneity in Colorectal Cancer: What Do We Know So Far?
Sagaert, X., Vanstapel, A., & Verbeek, S. (2018) · Pathobiology · doi:10.1159/000486721 · Cited by 172
Khorana, A. A., Ryan, C., Cox, C., Eberly, S. W., & Sahasrabudhe, D. M. (2003) · Cancer · doi:10.1002/cncr.11152 · Cited by 170
Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer
Jeong, H., Hwang, I., Kang, S. H., Shin, H. C., & Kwon, S. Y. (2019) · Journal of Breast Cancer · doi:10.4048/jbc.2019.22.e5 · Cited by 169
Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer
Casadaban, L. C., Rauscher, G. H., Aklilu, M., Villenes, D., Freels, S. A., & Maker, A. V. (2016) · Cancer · doi:10.1002/cncr.30181 · Cited by 168
Ålgars, A., Irjala, H., Vaittinen, S., Huhtinen, H., Sundström, J., Salmi, M., Ristamäki, R., & Jalkanen, S. (2012) · International Journal of Cancer · doi:10.1002/ijc.26457 · Cited by 167
Parra, E. R., Villalobos, P., Behrens, C., Jiang, M., Pataer, A., Swisher, S. G., William, W. N., Zhang, J., Lee, J., Cascone, T., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0368-0 · Cited by 167
Rakaee, M., Busund, L.-T. R., Jamaly, S., Paulsen, E.-E., Richardsen, E., Andersen, S., Al-Saad, S., Bremnes, R. M., Donnem, T., & Kilvaer, T. K. (2019) · Neoplasia · doi:10.1016/j.neo.2019.01.005 · Cited by 166
Liu, Z., Xie, Y., Xiong, Y., Liu, S., Qiu, C., Zhu, Z., Mao, H., Yu, M., & Wang, X. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.10.020 · Cited by 164
Intratumoral macrophage counts correlate with tumor progression in colorectal cancer
Kang, J., Chen, J., Lee, C., Chang, J., & Shieh, Y. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21617 · Cited by 161
M2 tumor‑associated macrophages promote tumor progression in non‑small‑cell lung cancer
Sumitomo, R., Hirai, T., Fujita, M., Murakami, H., Otake, Y., & Huang, C. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8068 · Cited by 160
Park, S.-Y., Jung, M.-Y., Lee, S.-J., Kang, K.-B., Gratchev, A., Riabov, V., Kzhyshkowska, J., & Kim, I.-S. (2009) · Journal of Cell Science · doi:10.1242/jcs.049569 · Cited by 158
Self-citationLanciotti, M., Masieri, L., Raspollini, M. R., Minervini, A., Mari, A., Comito, G., Giannoni, E., Carini, M., Chiarugi, P., & Serni, S. (2014) · BioMed Research International · doi:10.1155/2014/486798 · Cited by 157
Yousefi, M., Nosrati, R., Salmaninejad, A., Dehghani, S., Shahryari, A., & Saberi, A. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0376-6 · Cited by 157
Koelzer, V. H., Canonica, K., Dawson, H., Sokol, L., Karamitopoulou, E., Lugli, A., & Zlobec, I. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1106677 · Cited by 156
Limagne, E., Thibaudin, M., Nuttin, L., Spill, A., Dérangère, V., Fumet, J.-D., Amellal, N., Peranzoni, E., Cattan, V., & Ghiringhelli, F. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0228 · Cited by 155
Steitz, A. M., Steffes, A., Finkernagel, F., Unger, A., Sommerfeld, L., Jansen, J. M., Wagner, U. A. G., Graumann, J., Müller, R., & Reinartz, S. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2438-8 · Cited by 155
TREM-1 Expression in Tumor-associated Macrophages and Clinical Outcome in Lung Cancer
Ho, C., Liao, W., Wang, C.-Y., Lu, Y.-H., Huang, H., Chen, H., Chan, W., Chen, H., & Yang, P. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200704-641oc · Cited by 154
Dai, F., Liu, L., Che, G., Yu, N., Pu, Q., Zhang, S., Ma, J., Ma, L., & You, Z. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-220 · Cited by 153
The Role of Tumor-Associated Macrophages in Colorectal Carcinoma Progression
Zhong, X., Chen, B., & Yang, Z. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000486816 · Cited by 153
Feng, Q., Chang, W., Mao, Y., He, G., Zheng, P., Tang, W., Wei, Y., Ren, L., Zhu, D., Ji, M., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2076 · Cited by 152
Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications
Roelands, J. P., Kuppen, P. J. K., Vermeulen, L., Maccalli, C., Decock, J. V., Wang, E., Marincola, F. M., Bedognetti, D., & Hendrickx, W. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102229 · Cited by 150
Yang, C., Chen, W., Wang, S., Shi, D., Zhang, C., Lin, X., Dou, R., & Xiong, B. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.29836 · Cited by 149
Shabo, I., Olsson, H., Sun, X., & Svanvik, J. (2009) · International Journal of Cancer · doi:10.1002/ijc.24506 · Cited by 148
Mohammed, Z. M. A., Going, J. J., Edwards, J., Elsberger, B., Doughty, J., & McMillan, D. C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.347 · Cited by 148
Zhang, Y., Cheng, S., Zhang, M., Zhen, L., Pang, D., Zhang, Q., & Li, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076147 · Cited by 146
Khosravi‐Shahi, P., Cabezón‐Gutiérrez, L., & Custodio‐Cabello, S. (2017) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12748 · Cited by 144
Baci, D., Bosi, A., Gallazzi, M., Rizzi, M., Noonan, D. M., Poggi, A. D., Bruno, A., & Mortara, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093125 · Cited by 144
M2 macrophages promote NSCLC metastasis by upregulating CRYAB
Guo, Z., Song, J., Hao, J., Zhao, H., Du, X., Li, E., Kuang, Y., Yang, F., Wang, W. T., Deng, J., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1618-x · Cited by 142
Transcriptional, Epigenetic and Metabolic Programming of Tumor-Associated Macrophages
Larionova, I., Kazakova, E., Patysheva, M. R., & Kzhyshkowska, J. G. (2020) · Cancers · doi:10.3390/cancers12061411 · Cited by 138
Self-citationRole of chitinase-like proteins in cancer
Kzhyshkowska, J. G., Yin, S., Liu, T., Riabov, V., & Larionova, I. (2016) · Biological Chemistry · doi:10.1515/hsz-2015-0269 · Cited by 137
Self-citationEsbona, K., Yi, Y., Saha, S., Yu, M., Doorn, R. R. V., Conklin, M. W., Graham, D., Wisinski, K. B., Ponik, S. M., Eliceiri, K. W., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.10.025 · Cited by 135
Zhang, B. C., Gao, J., Wang, J., Rao, Z. G., Wang, B. C., & Gao, J. F. (2010) · Medical Oncology · doi:10.1007/s12032-010-9638-5 · Cited by 134
Gwak, J. M., Jang, M. H., Kim, D. I., Seo, A. N., & Park, S. Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125728 · Cited by 132
Chen, Y., Tan, W., & Wang, C. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s168317 · Cited by 131
Tariq, M., Zhang, J., Liang, G., He, Q., Ding, L., & Yang, B. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.124 · Cited by 129
Carus, A., Ladekarl, M. B., Hager, H., Pilegaard, H. K., Nielsen, P. S., & Donskov, F. N. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.03.003 · Cited by 128
Molecular pathology of lung cancer: current status and perspectives
Oberndorfer, F., & Müllauer, L. (2017) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000429 · Cited by 128
Zhang, W., Wang, X., Gao, S.-T., Chen, C., Xu, X., Sun, Q., Zhou, Z.-H., Wu, G.-Z., Yu, Q., Xu, G., et al. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.09.035 · Cited by 126
Zhu, L., Narloch, J. L., Onkar, S., Joy, M., Broadwater, G., Luedke, C., Hall, A. H. S., Kim, R., Pogue–Geile, K. L., Sammons, S. L., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0755-1 · Cited by 125
Malesci, A., Bianchi, P., Celesti, G., Basso, G., Marchesi, F., Grizzi, F., Di Caro, G., Cavalleri, T., Rimassa, L., Palmqvist, R., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1342918 · Cited by 124
Tyekucheva, S., Bowden, M., Bango, C., Giunchi, F., Huang, Y., Zhou, C. W., Bondi, A., Lis, R. T., Hemelrijck, M. V., Andrén, O., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00460-4 · Cited by 124
Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk
Sarode, P., Schaefer, M. B., Grimminger, F., Seeger, W., & Savai, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00324 · Cited by 123
Gartung, A., Yang, J., Sukhatme, V. P., Bielenberg, D. R., Fernandes, D., Chang, J., Schmidt, B. A. R., Hwang, S. H., Zurakowski, D., Huang, S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803999116 · Cited by 121
Koru‐Sengul, T., Santander, A. M., Miao, F., Sanchez, L. G., Jordà, M., Glück, S., Ince, T. A., Nadji, M., Chen, Z., Penichet, M. L., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3847-3 · Cited by 118
Brasso, K., Christensen, I. J., Johansen, J. S., Teisner, B., Garnero, P., Price, P. A., & Iversen, P. (2005) · The Prostate · doi:10.1002/pros.20311 · Cited by 116
Peng, H., Chen, B., Huang, W., Tang, Y., Jiang, Y., Zhang, W., & Huang, Y. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03756 · Cited by 116
Activated macrophages induce metastatic behavior of colon cancer cells
Jedinak, A., Dudhgaonkar, S. P., & Slíva, D. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.03.004 · Cited by 114
Reinartz, S., Finkernagel, F., Adhikary, T., Rohnalter, V., Schumann, T., Schober, Y., Nockher, W. A., Nist, A., Stiewe, T., Jansen, J. M., et al. (2016) · Genome biology · doi:10.1186/s13059-016-0956-6 · Cited by 113
Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis
Liu, W., Wang, W., Wang, X., Xu, C., Zhang, N., & Di, W. J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.024 · Cited by 113
Miyasato, Y., Shiota, T., Ohnishi, K., Pan, C., Yano, H., Horlad, H., Yamamoto, Y., Yamamoto‐Ibusuki, M., Iwase, H., Takeya, M., et al. (2017) · Cancer Science · doi:10.1111/cas.13287 · Cited by 111
Tumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis
Yin, M., Shen, J., Yu, S., Jing, F., Zhu, X., Zhao, J., Zhai, L., Sadhukhan, A., & Zhou, J. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s216355 · Cited by 111
Liu, R., Hu, R., Zeng, Y., Zhang, W., & Zhou, H. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.102602 · Cited by 111
Pelekanou, V., Villarroel‐Espíndola, F., Schalper, K. A., Pusztai, L., & Rimm, D. L. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1076-x · Cited by 109
Gerber, B., Freund, M., & Reimer, T. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0085 · Cited by 108
Imatinib prevents lung cancer metastasis by inhibiting M2-like polarization of macrophages
Yao, Z., Zhang, J., Zhang, B., Liang, G., Chen, X., Yao, F., Xu, X., Wu, H., He, Q., Ding, L., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.05.002 · Cited by 108
Chen, W., Yang, C., Wang, S., Shi, D., Zhang, C., Lin, X., & Xiong, B. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s198126 · Cited by 107
Fleur, L. L., Boura, V. F., Alexeyenko, A., Berglund, A., Pontén, V., Mattsson, J. S. M., Djureinovic, D., Persson, J., Brunnström, H., Isaksson, J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31545 · Cited by 106
Chung, F., Lee, K., Wang, C., Heh, C., Chan, Y., Chen, H., Kuo, C. S., Feng, P., Lin, T., Wang, C., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.27403 · Cited by 105
Liu, Q., Tong, D., Liu, G., Gao, J., Wang, L.-A., Xu, J., Yang, X., Xie, Q., Huang, Y., Pang, J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0420 · Cited by 104
Activation of Tumor-Promoting Type 2 Macrophages by EGFR-Targeting Antibody Cetuximab
Pander, J., Heusinkveld, M., van der Straaten, T., Jordanova, E. S., Baak-Pablo, R., Gelderblom, H., Morreau, H., van der Burg, S. H., Guchelaar, H.-J., & van Hall, T. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0239 · Cited by 101
Lundholm, M., Hägglöf, C., Wikberg, M. L., Stattin, P. E., Egevad, L., Bergh, A. R. J., Wikström, P., Palmqvist, R., & Edin, S. (2015) · Scientific Reports · doi:10.1038/srep15651 · Cited by 100
Multifunctional Receptor Stabilin-1 in Homeostasis and Disease
Kzhyshkowska, J. G. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.189 · Cited by 99
Self-citationVSIG4 expression on macrophages facilitates lung cancer development
Liao, Y., Guo, S. J., Chen, Y., Cao, D., Xu, H., Yang, C., Fei, L., Ni, B., & Ruan, Z. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.73 · Cited by 99
Zhang, X., Chen, Y., Hao, L., Hou, A., Chen, X., Li, Y., Wang, R., Luo, P., Ruan, Z., Ou, J., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.08.004 · Cited by 99
Finkernagel, F., Reinartz, S., Lieber, S., Adhikary, T., Wortmann, A., Hoffmann, N., Bieringer, T., Nist, A., Stiewe, T., Jansen, J. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12180 · Cited by 99
Page, C. L., Marineau, A., Bonza, P. K., Rahimi, K., Cyr, L., Labouba, I., Madore, J., Delvoye, N., Mes‐Masson, A., Provencher, D. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038541 · Cited by 98
Ni, C., Liu, Y., Xu, Q., Yuan, H., Wang, W. T., Xia, W., Gong, D.-H., Zhang, W., & Yu, K. (2019) · Journal of Cancer · doi:10.7150/jca.33914 · Cited by 97
Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy
Gupta, V. G., Yull, F. E., & Khabele, D. (2018) · Cancers · doi:10.3390/cancers10100366 · Cited by 96
Li, Y., Wang, F., Wang, L., Huang, L. J., Wang, J., Zhang, B., & Zhang, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.3547 · Cited by 95
Remark, R., Mansuet‐Lupo, A., Alifano, M., Biton, J., Ouakrim, H., Stefani, A. D., Cremer, I., Goc, J., Régnard, J., Dieu‐Nosjean, M., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1255394 · Cited by 92
Four Molecular Subtypes of Colorectal Cancer and Their Precursor Lesions
Kang, G. H. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2010-0523-ra.1 · Cited by 92
YKL-40/CHI3L1 drives inflammation on the road of tumor progression
Libreros, S., & Iragavarapu‐Charyulu, V. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3vmr0415-142r · Cited by 91
Kzhyshkowska, J. G., Gratchev, A. N., MARTENS, J. H., Pervushina, O., Mamidi, S., Johansson, S., Schledzewski, K., Hansen, B., He, X., Tang, J., et al. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0504300 · Cited by 89
Self-citationSorrentino, C., Musiani, P., Pompa, P., Cipollone, G., & Carlo, E. D. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2804 · Cited by 87
Zhou, J., Wang, X.-H., Zhao, Y., Chen, C., Xu, X., Sun, Q., Wu, H., Chen, M., Sang, J., Su, L., et al. (2018) · Journal of Cancer · doi:10.7150/jca.28583 · Cited by 87
Ramos, R. N., Rodriguez, C., Hubert, M., Ardin, M., Treilleux, I., Ries, C. H., Lavergne, E., Chabaud, S., Colombe, A., Trédan, O., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1108 · Cited by 85
Dijkgraaf, E. M., Santegoets, S. J. A. M., Reyners, A. K. L., Goedemans, R., Nijman, H. W., van Poelgeest, M. I. E., van Erkel, A. R., Smit, V. T. H. B. M., Daemen, T., van der Hoeven, J. J. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4772 · Cited by 84
Yang, M., Li, Z., Ren, M., Li, S., Zhang, L., Zhang, X., & Liu, F. (2018) · Journal of Cancer · doi:10.7150/jca.25155 · Cited by 84
Yin, W., Yu, X., Kang, X., Zhao, Y., Zhao, P., Jin, H., Fu, X., Wan, Y., Peng, C., & Huang, Y. (2018) · Small · doi:10.1002/smll.201802372 · Cited by 84
Sun, F., Cui, L., Li, T., Chen, S., Jun-mei, S., & Li, D. (2019) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2019.1655050 · Cited by 83
Gollapudi, K., Galet, C., Grogan, T., Zhang, H., Said, J. W., Huang, J., Elashoff, D. A., Freedland, S. J., Rettig, M. B., & Aronson, W. J. (2013) · Europe PMC (PubMed Central) · Cited by 82
The prognostic impact of M‐CSF, CSF‐1 receptor, CD68 and CD3 in prostatic carcinoma
Richardsen, E. H., Uglehus, R. D., Due, J., Busch, C., & Busund, L.-T. R. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03058.x · Cited by 82
Hu, W., Yunjuan, Q., Feng, Y. Y., Liu, W., Wu, Y., Fang, X., & Hao, W. (2015) · Oncology Letters · doi:10.3892/ol.2015.3400 · Cited by 81
How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment
Saraiva, D. P., Cabral, M. G., Jacinto, A., & Braga, S. A. (2017) · ESMO Open · doi:10.1136/esmoopen-2017-000208 · Cited by 81
Hirayama, S., Ishii, G., Nagai, K., Ono, S., Kojima, M., Yamauchi, C., Aokage, K., Hishida, T., Yoshida, J., Suzuki, K., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182745968 · Cited by 79
Wang, C., Peng, G., Huang, H., Liu, F., Kong, D.-P., Dong, K., Dai, L., Zhou, Z., Wang, K., Yang, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2446 · Cited by 78
Li, Z., Maeda, D., Yoshida, M., Umakoshi, M., Nanjo, H., Shiraishi, K., Saito, M., Kohno, T., Konno, H., Saito, H., et al. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.07.015 · Cited by 78
Liu, T., Larionova, I., Литвяков, Н. В., Riabov, V., Zavyalova, M. V., Tsyganov, M. M., Buldakov, M. A., Song, B., Moganti, K., Вадимовна, К. П., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1436922 · Cited by 77
Self-citationCD163 and CCR7 as markers for macrophage polarisation in lung cancer microenvironment
Kwiecień, I., Polubiec-Kownacka, M., Dziedzic, D. A., Wołosz, D., Rzepecki, P., & Domagala-Kulawik, J. J. (2020) · Central European Journal of Immunology · doi:10.5114/ceji.2019.92795 · Cited by 77
Nakayama, Y., Nagashima, N., Minagawa, N., Inoue, Y., Katsuki, T., Onitsuka, K., 佐古, 達., Hirata, K., Nagata, N., & Itoh, H. (2002) · PubMed · Cited by 76
Zarif, J. C., Valle, J. A. B.-D., Hicks, J. L., Heaphy, C. M., Vidal, I., Luo, J., Lotan, T. L., Hooper, J. E., Isaacs, W. B., Pienta, K. J., et al. (2018) · European Urology Oncology · doi:10.1016/j.euo.2018.09.014 · Cited by 76
Markers of Cancer Cell Invasion: Are They Good Enough?
Gerashchenko, T. S., Novikov, N. M., Krakhmal, N. V., Zolotareva, S. Y., Zavyalova, M. V., Чердынцева, Н. В., Denisov, E. V., & Михайлович, П. В. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081092 · Cited by 74
Carcinoma origin dictates differential skewing of monocyte function
Bögels, M., Braster, R., Nijland, P. G., Gül, N., van de Luijtgaarden, W., Fijneman, R. J. A., Meijer, G. A., Jiménez, C. R., Beelen, R. H. J., & van Egmond, M. (2012) · OncoImmunology · doi:10.4161/onci.20427 · Cited by 73
Cavnar, M. J., Turcotte, S., Katz, S. C., Kuk, D., Gönen, M., Shia, J., Allen, P. J., Balachandran, V. P., D'Angelica, M. I., Kingham, T. P., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-5812-8 · Cited by 73
Tumor-Associated Macrophages Induce Endocrine Therapy Resistance in ER+ Breast Cancer Cells
Castellaro, A. M., Rodríguez-Baili, M. C., Tada, C. D., & Gil, G. A. (2019) · Cancers · doi:10.3390/cancers11020189 · Cited by 72
Xuan, Q., Wang, J., Nanding, A., Wang, Z., Liu, H., Lian, X., & Zhang, Q. (2014) · Pathology & Oncology Research · doi:10.1007/s12253-013-9740-z · Cited by 70
Zhang, W., Chen, L., Ma, K., Zhao, Y., Liu, X., Wang, Y., Liu, M., Liang, S., Zhu, H., & Xu, N. (2016) · Oncotarget · doi:10.18632/oncotarget.12207 · Cited by 70
Cited by
The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression
Wang, H., Yung, M. M. H., Ngan, H. Y. S., Chan, K. K. L., & Chan, D. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126560 · Cited by 254
The role of tumor-associated macrophages in tumor immune evasion
Huang, R., Kang, T., & Chen, S. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05777-4 · Cited by 230
Extracellular Matrix Cues Regulate Mechanosensing and Mechanotransduction of Cancer Cells
Mierke, C. T. (2024) · Cells · doi:10.3390/cells13010096 · Cited by 146
Tumor-associated macrophage polarization in the inflammatory tumor microenvironment
Zou, Z., Lin, H., Li, M., & Lin, B. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1103149 · Cited by 100
Thymosin α-1 Reverses M2 Polarization of Tumor-Associated Macrophages during Efferocytosis
Wei, Y.-T., Wang, X.-R., Yan, C., Huang, F., Zhang, Y., Liu, X., Wen, Z.-F., Sun, X.-T., Zhang, Y., Chen, Y.-Q., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4260 · Cited by 80
Metadata
- Authors
- Larionova, I., Tuguzbaeva, G., Ponomaryova, A., Stakheyeva, M., Cherdyntseva, N., Pavlov, V., Choinzonov, E., & Kzhyshkowska, J.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2020-10-22
- Volume
- 10
- Pages
- 566511-566511
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W3093826348
- Cited by
- 392
- References
- 276
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.